Sleep in infants with congenital myasthenic syndromes

Serena Caggiano1, Sonia Khirani2, Elisabetta Verrillo3

  • 1Respiratory Unit, Academic Pediatric Department, Bambino Gesù Children's Hospital, Rome, Italy; AP-HP, Hôpital Necker-Enfants Malades, Pediatric Noninvasive Ventilation and Sleep Unit, Paris, France.

Insights

Infants with congenital myasthenic syndrome (CMS) often have abnormal breathing during sleep, requiring intervention. Heart rate (HR) variability was not significantly altered in these infants during sleep studies.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Genetics

Background:

  • Congenital myasthenic syndrome (CMS) infants are susceptible to brief resolved unexplained events (BRUE) and sleep-disordered breathing.
  • Understanding sleep patterns and cardiorespiratory events in CMS is crucial for management.

Purpose of the Study:

  • To investigate sleep characteristics in infants with CMS.
  • To specifically analyze heart rate (HR) variability in relation to respiratory events.

Main Methods:

  • Overnight polygraphy was conducted on 5 infants with CMS.
  • Heart rate (HR) variations (bradycardia/tachycardia) associated with respiratory events were analyzed.
  • Apnea-hypopnea index (AHI) and transcutaneous gas exchange were assessed.

Main Results:

  • All infants exhibited abnormal AHI, with higher values in younger infants.
  • Three infants required ventilatory support post-study due to high AHI or hypoventilation.
  • No significant abnormalities in HR variations were detected during sleep studies.

Conclusions:

  • Sleep polygraphy is clinically valuable for identifying respiratory abnormalities in CMS infants.
  • Early identification of sleep-disordered breathing and hypoventilation can guide timely intervention.
  • While respiratory events are common, significant HR variability abnormalities were not observed in this cohort.
Abstract

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.8K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.1K
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
955
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K